AwardTape · Defense awards · Research and development · Defense systems R&D · H9240522C0005
H9240522C0005: $0 definitive contract to Rejuvenate Bio Inc
Rejuvenate Bio Inc holds a definitive contract from U.S. Special Operations Command with $0 obligated since Oct 2023 and $3.0M obligated over its life, against a ceiling of $3.0M. Latest action Jun 7, 2024.
Sbir ph ii topic 182-002 neuroenhancement
| PIID | H9240522C0005 |
|---|---|
| Type | definitive contract |
| Company | Rejuvenate Bio Inc |
| Agency | U.S. Special Operations Command |
| Contracting office | HQ USSOCOM |
| Category | Research and development · Defense systems R&D |
| PSC | AC13 NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $3.0M |
| Ceiling (base and all options) | $3.0M |
| Base date | Jun 7, 2022 |
| Latest action | Jun 7, 2024 |
| End date | Dec 16, 2024 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost plus fixed fee |
| Competition | Competed after exclusion of sources |
| Place of performance | CA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial